How much does a box of Sunitinib cost in China?

Sunitinib is a tyrosine kinase inhibitor used to treat cancers such as metastatic renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. Although sunitinib prolongs survival in cancer patients, adverse cardiotoxic events such as left ventricular dysfunction, hypertension, and heart failure have been observed in clinical studies. Currently, no clinical biomarkers are available to predict the early onset of sunitinib-induced cardiotoxicity during cancer treatment.

Moving evidence suggests that microRNAs (miRNAs) may play a role in susceptibility to adverse drug reactions and have emerged as promising biomarkers of cardiovascular disease and treatment response. Heart function was measured by ultrasound imaging 24 hours after dosing and on days 0, 3, 6, 9, 12, and 21, and blood samples were collected to assess the myocardial injury markers cardiac troponin-1 (cTnI) and microRNAs (miRNAs).

The original sunitinib drug has been launched in China and has entered the scope of Class B medical insurance. SpecificationsThe price of 12.5mg*28 tablets is around RMB 3,500. The original sunitinib drug has also been launched overseas. The price of 12.5mg*7 tablets is around RMB 1,500 (the price may fluctuate due to the exchange rate). There are also generic drugs produced in other countries. The price of 12.5mg*28 tablets produced by an Indian pharmaceutical factory is around RMB 750 (the price may fluctuate due to the exchange rate). The generic drugs produced abroad are basically the same as the original drugs at home and abroad. There may be differences in the prices of different specifications of drugs.